Product
Invega Sustenna
1 clinical trial
12 indications
Indication
SchizophreniaIndication
Psychotic DisordersIndication
Mood DisordersIndication
Schizophrenia SpectrumIndication
Mental DisordersIndication
Antipsychotic AgentsIndication
AnxiolyticsIndication
CNS DepressantsIndication
PharmacodynamicsIndication
Psychotropic DrugsIndication
Neurotransmitter AgentsClinical trial
A Study to Evaluate the PK Profiles of LY03010 and Relative Bioavailability at Steady-state of LY03010 Versus INVEGA SUSTENNA in Schizophrenia PatientsStatus: Completed, Estimated PCD: 2022-03-15